Ypsomed Holding AG (YPHDF)
OTCMKTS · Delayed Price · Currency is USD
475.18
-2.39 (-0.50%)
At close: Aug 6, 2025
Ypsomed Holding AG Market Cap
Ypsomed Holding AG has a market cap or net worth of $7.22 billion as of September 18, 2025. Its market cap has increased by 8.16% in one year.
Market Cap
7.22B
Enterprise Value
7.51B
Revenue
847.18M
Ranking
n/a
PE Ratio
72.89
Stock Price
$475.18
Market Cap Chart
Since September 22, 2004, Ypsomed Holding AG's market cap has increased from 646.56M to 7.22B, an increase of 1,015.97%. That is a compound annual growth rate of 12.17%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 17, 2025 | 7.22B | 46.40% |
Dec 30, 2024 | 4.93B | 0.35% |
Dec 29, 2023 | 4.91B | 97.10% |
Dec 30, 2022 | 2.49B | -3.34% |
Dec 30, 2021 | 2.58B | 21.96% |
Dec 30, 2020 | 2.11B | 23.96% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Nika Pharmaceuticals | 982.68M |
Veradigm | 806.69M |
Elite Pharmaceuticals | 694.19M |
Tian'an Technology Group | 609.94M |
Glass House Brands | 567.62M |
Northwest Biotherapeutics | 378.51M |
CytoDyn | 368.77M |
American Oncology Network | 345.48M |